Published in Ann Surg Oncol on June 01, 1999
A Study of Bevacizumab to Prevent Malignant Ascites | NCT00908219
The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer (2009) 9.01
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer (2013) 1.93
Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol (2010) 1.73
Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia (2007) 1.45
Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg (2012) 1.43
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev (2012) 1.31
Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Br J Cancer (2005) 1.13
Malignant ascites: pathophysiology and treatment. Int J Clin Oncol (2012) 1.06
VEGF significance in peritoneal recurrence from gastric cancer. Gastric Cancer (2005) 1.06
Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment. Biochem J (2011) 1.05
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim Biophys Acta (2012) 1.04
Role of the cytoskeleton in formation and maintenance of angiogenic sprouts. J Vasc Res (2011) 1.01
ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer. Mol Cancer Ther (2009) 0.97
Role of VEGF and CD44v6 in differentiating benign from malignant ascites. World J Gastroenterol (2003) 0.95
Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer. Br J Cancer (2013) 0.93
A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA. PLoS Med (2008) 0.93
Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer. BMC Cancer (2012) 0.92
Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model. Transl Oncol (2010) 0.91
The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion. Curr Oncol Rep (2013) 0.90
Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations. Ann Surg Oncol (2008) 0.90
Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer. World J Gastroenterol (2002) 0.90
Antiangiogenic Steroids in Human Cancer Therapy. Evid Based Complement Alternat Med (2005) 0.87
Palliative treatment of malignant ascites: profile of catumaxomab. Biologics (2010) 0.86
Investigational agents in development for the treatment of ovarian cancer. Invest New Drugs (2012) 0.85
VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells. Clin Cancer Res (2016) 0.84
Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer. Cancer Res (2015) 0.84
Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model. J Nanobiotechnology (2015) 0.83
Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancer. Oncol Lett (2012) 0.82
Emerging treatment options for management of malignant ascites in patients with ovarian cancer. Int J Womens Health (2012) 0.81
Synergistic effects of Endostar combined with β-elemene on malignant ascites in a mouse model. Exp Ther Med (2012) 0.81
Incidence and management of ZIv-aflibercept related toxicities in colorectal cancer. World J Clin Oncol (2014) 0.81
Assessment of vascular endothelial growth factor in formalin fixed, paraffin embedded colon cancer specimens by means of a well-based reverse phase protein array. Proteome Sci (2014) 0.81
Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model. Surg Today (2010) 0.80
Prognostic and predictive value of serum vascular endothelial growth factor (VEGF) in squamous cell carcinoma of the head and neck. Oral Maxillofac Surg (2013) 0.80
Evaluation and treatment of malignant ascites secondary to gastric cancer. World J Gastroenterol (2015) 0.79
Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer. Surg Today (2014) 0.79
The clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascites. Int J Clin Exp Med (2014) 0.79
Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer. World J Crit Care Med (2013) 0.78
Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients. Yonsei Med J (2008) 0.77
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer. Ann Surg Oncol (2016) 0.76
Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer. Case Rep Oncol (2010) 0.75
Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Clin Exp Metastasis (2016) 0.75
Aiming to immune elimination of ovarian cancer stem cells. World J Stem Cells (2013) 0.75
Osterix transcriptional factor is involved in the metastasis of human breast cancers. Oncol Lett (2015) 0.75
Resveratrol and acetyl-resveratrol modulate activity of VEGF and IL-8 in ovarian cancer cell aggregates via attenuation of the NF-κB protein. J Ovarian Res (2016) 0.75
Malignant Pleural Effusion and Ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-Like Cell Properties via VEGF/PI3K/Akt/mTOR Pathway. J Biol Chem (2016) 0.75
Sustained Improvement in a Metastatic Colon Cancer Patient with FOLFIRI-Aflibercept after FOLFOX Failure. Case Rep Oncol (2015) 0.75
Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis. Medicine (Baltimore) (2016) 0.75
Novel pegylated interferon-β as strong suppressor of the malignant ascites in a peritoneal metastasis model of human cancer. Cancer Sci (2017) 0.75
Highly pathogenic H5N1 influenza virus infection in migratory birds. Science (2005) 9.64
7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med (2001) 7.05
PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet (1999) 6.18
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg (1999) 5.25
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res (1995) 4.84
The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell (1994) 4.35
Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry (2008) 4.14
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg (2000) 3.97
Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature (2000) 3.83
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A (2000) 3.61
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res (1997) 3.38
Prevalence and genetic diversity of coronaviruses in bats from China. J Virol (2006) 3.37
Human beta-globin gene expression in transgenic mice is enhanced by a distant DNase I hypersensitive site. Proc Natl Acad Sci U S A (1989) 2.92
Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem (1999) 2.89
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med (2001) 2.87
BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet (2001) 2.76
A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer (2008) 2.63
Pharmacodynamics of fluconazole in a murine model of systemic candidiasis. Antimicrob Agents Chemother (1998) 2.59
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet (1997) 2.56
Cytokinin action is coupled to ethylene in its effects on the inhibition of root and hypocotyl elongation in Arabidopsis thaliana seedlings. Plant Physiol (1995) 2.52
Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology (2000) 2.50
CA 125: the past and the future. Int J Biol Markers (1999) 2.50
Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol (1993) 2.46
Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology (2009) 2.41
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. Nat Med (2005) 2.28
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst (2001) 2.27
XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res (2001) 2.25
Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection. Antimicrob Agents Chemother (2001) 2.24
Large-scale concatenation cDNA sequencing. Genome Res (1997) 2.18
Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells. Cell Death Differ (2010) 2.17
Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science (1999) 2.14
In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res (2000) 2.08
In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol (2005) 2.07
The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene (1999) 2.07
Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents. Antimicrob Agents Chemother (1990) 2.03
Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg (1997) 2.01
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci U S A (1999) 2.00
Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology (2008) 2.00
Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res (1996) 2.00
PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene (1998) 1.98
Multiple-locus departures from panmictic equilibrium within and between village gene pools of Amerindian tribes at different stages of agglomeration. Genetics (1983) 1.93
Effect of conjugated linoleic acid on body composition in mice. Lipids (1997) 1.92
Transgenic mouse model for skin malignant melanoma. Oncogene (1998) 1.90
Heterogeneous distribution of the two components of delayed rectifier K+ current: a potential mechanism of the proarrhythmic effects of methanesulfonanilideclass III agents. Cardiovasc Res (1999) 1.89
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J (2001) 1.86
Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle. Cardiovasc Res (2000) 1.86
Dissection of the enhancer activity of beta-globin 5' DNase I-hypersensitive site 2 in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.84
Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet (1999) 1.83
Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J Biol Chem (2001) 1.82
A "double adaptor" method for improved shotgun library construction. Anal Biochem (1996) 1.81
Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene (1999) 1.81
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res (2001) 1.80
Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet (1993) 1.80
The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res (2001) 1.80
Coordinate repression of a trio of neuron-specific splicing events by the splicing regulator PTB. RNA (1999) 1.78
Regulation of left-right asymmetry by thresholds of Pitx2c activity. Development (2001) 1.77
Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res (2001) 1.77
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol (2001) 1.77
Lysophospholipids activate ovarian and breast cancer cells. Biochem J (1995) 1.76
Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int (1999) 1.76
Transmembrane ion fluxes during activation of human T lymphocytes: role of Ca2+, Na+/H+ exchange and phospholipid turnover. Immunol Rev (1987) 1.74
Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J Exp Med (1995) 1.73
Prevalence of helminths in water buffaloes in Hunan Province, China. Trop Anim Health Prod (2008) 1.72
Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3. Biophys J (2004) 1.71
Human damage-specific DNA-binding protein p48. Characterization of XPE mutations and regulation following UV irradiation. J Biol Chem (2000) 1.70
Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial. J Infect Dis (2007) 1.70
CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci U S A (1994) 1.70
The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences. Neuroscience (2003) 1.69
Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst (1996) 1.69
Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem (1999) 1.68
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. Br J Cancer (2006) 1.67
Terahertz response and colossal Kerr rotation from the surface states of the topological insulator Bi2Se3. Phys Rev Lett (2012) 1.67
Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann N Y Acad Sci (2000) 1.67
Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Mol Psychiatry (2010) 1.66
Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol (1999) 1.65
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. Br J Cancer (2012) 1.64
Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. J Natl Cancer Inst (1997) 1.63
The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol (2000) 1.63
In meso structure of the cobalamin transporter, BtuB, at 1.95 A resolution. J Mol Biol (2006) 1.62
The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet (1999) 1.61
Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J (2006) 1.61
Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain. J Biol Chem (1997) 1.61
Chloride secretory mechanism induced by prostaglandin E1 in a colonic epithelial cell line. J Clin Invest (1985) 1.61
Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor. Am J Physiol (1998) 1.60
Pho signal transduction network reveals direct transcriptional regulation of one two-component system by another two-component regulator: Bacillus subtilis PhoP directly regulates production of ResD. Mol Microbiol (1998) 1.60
Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer (2000) 1.58
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res (1995) 1.57
Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Am J Hum Genet (1999) 1.56
Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet (1997) 1.53
Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res (2000) 1.53
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ (2009) 1.52
Cloning and functional expression of a cDNA encoding a pheromone gland-specific acyl-CoA Delta11-desaturase of the cabbage looper moth, Trichoplusia ni. Proc Natl Acad Sci U S A (1998) 1.52
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res (1998) 1.52